Hughes Hubbard & Reed advised ANI, while DLA Piper advised Alimera Sciences on the deal. Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions,...
ANI Pharmaceuticals’ Acquisition of Alimera Sciences
BillingPlatform’s US$90 Million Equity Growth Investment
DLA Piper represented BillingPlatform in the transaction. BillingPlatform, an enterprise revenue lifecycle management solutions provider, secured a significant US$90 million growth equity investment from FTV Capital, a...
Marlin Equity Partners’ Investment in TRAFiX
DLA Piper advised TRAFiX, while Goodwin Proctor advised Marlin on the deal. TRAFiX, a leading provider of order and execution management software (OEMS) and FIX connectivity...